Abstract
During the last years, a direct link between DNA methylation and repressive chromatin structure has been established. This structural modification is mediated by histone deacetylases targeted to the methylated sequences by Methyl Binding Proteins (MBD). Human cancer cells exhibit both a global hypomethylation and some localized hypermethylations suggesting that the deregulation of the methylation machinery is a central event in tumorigenesis. Therefore, we have investigated in human tissues the expression of two major MBDs, MeCP2 and MBD2, during the proliferation of normal breast and in benign and neoplasic breast tumors. Quantitation of the transcripts indicates that MBD2 mRNAs are 20–30-fold more abundant than MeCP2 transcripts in the adult and fetal human mammary gland. In pathological tissues samples MBD2 mRNA levels are significantly higher (P=0.001) in benign tumors compared with normal breast tissues, whereas MeCP2 expression is not modified in these specimens. In neoplasic samples a deregulation of the expression of both genes was found. The amounts of MBD2 and MeCP2 transcripts vary greatly between samples in cancer cells compared to normal breast tissues or benign tumors, and in invasive ductal carcinomas the amount of MBD2 mRNA is significantly (P=0.03) associated with the tumor size. Taken together these data suggest that upregulation of MBD2 might be associated with breast cell proliferation. In line with this hypothesis MBD2 is also upregulated during the prenatal development of the human mammary gland, but in contrast to that observed in tumor cells, MeCP2 is also coordinately upregulated in the fetal breast tissues, suggesting that deregulation of MeCP2 and MBD2 occurs in human breast cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arnaud M, Dante R, Niveauleau A . 1985 Biochem. Biophys. Res. Commun. 13: 108–112
Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . 1997 Adv. Cancer Res. 72: 141–196
Bernardino J, Roux C, Almeida A, Vogt N, Gibaud A, Gerbault-Seureau M, Magdelenat H, Bourgeois CA, Malfoy B, Dutrillaux B . 1997 Cancer Genet. Cytogenet. 97: 83–89
Bird AP, Wolffe AP . 1999 Cell 99: 451–454
Chen RZ, Akbarian S, Tudor M, Jaenisch R . 2001 Nat. Genet. 27: 327–331
Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C . 2000 Nat. Genet. 24: 132–138
Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, Laird PW . 2001 Cancer Res. 61: 3410–3418
Ehrlich M . 2000 DNA Hypomethylation and Cancer in DNA Alterations in Cancer Ehrlich M (ed) Natich, MA: Eaton Publishing pp 273–291
Guy J, Hendrich B, Holmes M, Martin JE, Bird A . 2001 Nat. Genet. 27: 322–326
Hendrich B, Bird A . 1998 Mol. Cell. Biol. 18: 6538–6547
Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A . 2001 Genes Dev. 15: 710–723
Jones PL, Veenstra GJC, Wade PA, Vermaak D, Kass SU, Landsberger N, Stroboulis J, Wolffe AP . 1998 Nat. Genet. 19: 187–191
Kaludov NK, Wolffe AP . 2000 Nucleic Acids Res. 28: 1921–1928
Kanai Y, Ushijima S, Nakanishi Y, Hirohashi S . 1999 Biochem. Biophys. Res. Commun. 264: 962–966
Li E, Bestor TH, Jaenisch R . 1992 Cell 69: 915–926
Magdinier F, Dalla Venezia N, Lenoir GM, Frappart L, Dante R . 1999 Oncogene 18: 4039–4043
Magdinier F, Wolffe AP . 2001 Proc. Natl. Acad. Sci. USA 24: 4990–4995
Meehan RR, Lewis JD, Bird AP . 1992 Nucleic Acids Res. 11: 5085–5092
Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP . 1989 Cell 58: 499–507
Nan X, Campoy FJ, Bird A . 1997 Cell 88: 471–481
Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A . 1998 Nature 393: 386–389
Ng HH, Jeppesen P, Bird A . 2000 Mol. Cell. Biol. 20: 1394–1406
Ng HH, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument-Bromage H, Tempst P, Reinberg D, Bird A . 1999 Nat. Genet. 23: 58–61
Poulsen HE, Taylor CW, Sobin LH . 1975 Histological typing of female genital tract tumors International histological classification of tumors World Health Organization, Geneva 13
Ribieras S, Magdinier F, Leclerc D, Lenoir G, Frappart L, Dante R . 1997 Int. J. Cancer 73: 715–718
Robertson KD, Jones PA . 2000 Carcinogenesis 21: 461–467
Russo J, Russo IH . 1987 The mammary gland. Development, Regulation and Function Neville MC and Daniel CW (eds) New York: Plenum Press pp 67–93
Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S . 2001 Hepatology 33: 561–568
Tanner JM . 1962 Growth at Adolescence Tanner JM (ed) Oxford: Blackwell Scientific pp 28–39
Tate P, Skarnes W, Bird A . 1996 Nat. Genet. 12: 205–208
Tate PH, Bird AP . 1993 Curr. Opin. Genet. Dev. 3: 226–231
Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, Wolffe AP . 1999 Nat. Genet. 23: 62–66
Wade PA . 2001 Oncogene 20: 3166–3173
Xu GL, Bestor TH, Bourc'his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E . 1999 Nature 11: 187–191
Yu F, Thiesen J, Stratling WH . 2000 Nucleic Acids Res. 15: 2201–2206
Zhou X, Marks PA, Rifkind RA, Richon VM . 2001 Proc. Natl. Acad. Sci. USA. 98: 10572–10577
Acknowledgements
We are most grateful to Drs Alan Wolffe and Paul Wade for providing MBD2 antibodies. We thank Dr Nicole Dalla Venezia for critical reading of this manuscript. The present work was supported by the Ligue Nationale pour la Recherche contre le Cancer, Comité de Saône et Loire and Comité du Rhône and the Association pour la Recherche contre le Cancer.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Billard, LM., Magdinier, F., Lenoir, G. et al. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene 21, 2704–2712 (2002). https://doi.org/10.1038/sj.onc.1205357
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205357
Keywords
This article is cited by
-
Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal status
Breast Cancer Research (2005)
-
Deficiency of Mbd2 suppresses intestinal tumorigenesis
Nature Genetics (2003)
-
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
British Journal of Cancer (2003)